RAD23B and sarcoma: A genome-wide screen revealed RAD23B, a protein that shuttles ubiquitinated proteins to the proteasome, is a biomarker for sensitivity to HDAC inhibition in cutaneous T-cell lymphoma [49, 50], and this relationship has been further demonstrated to also apply in sarcomas [51].